Skip to content

Clinical trials

Observational Heart Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Heart Diseases Phase: Observational Country / region: United States Clear all

211 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20025
20035
200410
20058
20065
20076
200811
20097
20108
20115
20126
201311
20146
20155
20167
20178
20186
20197
202010
202114
20226
20234
20246
20259
20267

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed132
Recruiting22
Active, not recruiting19
Unknown status13
Terminated9
Withdrawn9
Not yet recruiting4
Enrolling by invitation3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)16
Columbia University8
Mayo Clinic8
National Institute of Environmental Health Sciences (NIEHS)5
Edwards Lifesciences4
Abbott Medical Devices3
Cedars-Sinai Medical Center3
Duke University3
Johns Hopkins University3
Medtronic Cardiac Rhythm and Heart Failure3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Diseases211
Cardiovascular Diseases70
Coronary Artery Disease27
Coronary Disease21
Diabetes Mellitus21
Heart Failure21
Stroke16
Atherosclerosis15
Hypertension15
Myocardial Infarction11

Trials

Showing 1 to 25 of 211. Each trial links to its page on Pharma Observatory.

111 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.